HAEMOPHILIA is a leading peer-reviewed journal published by Wiley, dedicated to advancing research and clinical practices in the fields of hematology and genetics. With an impressive Impact Factor and recognition within the Q1 category for Genetics (clinical), Hematology, and Medicine (miscellaneous), this journal presents a unique platform for the dissemination of high-quality research from 1995 to the present. Researchers in these dynamic fields will find invaluable insights through original articles, systematic reviews, and clinical trials, all aimed at improving therapeutic strategies and patient outcomes. Although it operates on a subscription basis, HAEMOPHILIA's commitment to excellence is reflected in its Scopus rankings, where it stands in the 74th percentile for hematology and the 71st percentile for clinical genetics. As an essential resource for academics, healthcare professionals, and students, HAEMOPHILIA plays a pivotal role in fostering innovation and collaboration within the global medical community.

Egyptian Journal of Dermatology and Venereology is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Published by Wolters Kluwer Medknow Publications, this journal provides a vital platform for researchers, clinicians, and healthcare professionals to share cutting-edge research, case studies, and reviews that contribute to the understanding and treatment of skin and sexually transmitted diseases. With an ISSN of 1110-6530 and an E-ISSN of 2314-7407, the journal ensures global accessibility and visibility of its content, fostered by its commitment to high-quality publications. Although it operates with restricted access, the Egyptian Journal of Dermatology and Venereology remains an essential resource for practitioners and academics alike, supporting the dissemination of knowledge and innovation in skin health. Situated in Mumbai, India, the journal reflects a diverse pool of contributions that enrich our understanding of dermatological practices and principles on an international scale.

JAMA Oncology, published by the American Medical Association, stands at the forefront of cancer research as a premier peer-reviewed journal in the field. With an ISSN of 2374-2437 and an impressive impact factor reflecting its critical insights, the journal has achieved a top-tier position, being ranked in the Q1 quartile for both Cancer Research and Oncology as of 2023, and demonstrating exceptional performance in Medicine as well. Spanning a converged publication period from 2015 through 2024, JAMA Oncology publishes cutting-edge research, clinical trials, and reviews that are pivotal in advancing our understanding and treatment of cancer. The journal's Scopus ranks highlight its global impact, placing it in the top deciles within its categories, ensuring that it remains a vital resource for oncologists, researchers, and students alike. While it currently does not offer open access, JAMA Oncology continues to provide invaluable contributions to the scientific community, promoting a deeper understanding of oncological challenges and breakthroughs.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, published by Wiley, is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Since its inception in 1991, this esteemed journal has established itself as a vital resource, providing a platform for innovative research and critical analysis in these important medical disciplines. With an impressive Impact Factor stemming from its Q1 category ranks in both dermatology and infectious diseases, it has achieved a dominant position, ranking #4 out of 142 in Dermatology and #37 out of 344 in Infectious Diseases according to Scopus. Researchers and clinicians alike are encouraged to engage with the rich content and robust discussions presented in its pages, fostering collaboration and cutting-edge advancements in patient care. Access options to this journal can be explored through Wiley, allowing for widespread dissemination and engagement in the academic community. The journal’s ongoing commitment to excellence ensures its relevance and significance in shaping the future of dermatological and venereological research.

The Journal of Mid-life Health, published by Wolters Kluwer Medknow Publications, serves as a crucial platform for researchers and practitioners focusing on the multifaceted aspects of health during middle age. With a commitment to open access since 2010, this journal ensures that valuable research is available to a broad audience, fostering scholarly discussion and innovation in the field. Its ISSN is 0976-7800 and E-ISSN 0976-7819, making it easily identifiable in academic databases. Currently rated in the Q3 quartile in both health (social science) and miscellaneous medicine categories for 2023, the journal is positioned among the top tier of its peers, reflecting its significance in these domains. The journal ranks #222 in the Medicine (miscellaneous) category and #223 in Social Sciences (health) according to Scopus, showcasing its impact and relevance in contemporary discourse around mid-life health challenges. Researchers, health professionals, and students alike can benefit from the journal’s comprehensive articles, which span a variety of topics essential for understanding and improving health outcomes in middle age.

Basic and Clinical Andrology, published by BMC, is a leading open access journal dedicated to the advancement of knowledge in the field of reproductive medicine and urology. Since its launch in 2013, the journal has aimed to provide a platform for the dissemination of high-quality research, bridging the gap between basic science and clinical practice. With an impressive reputation evidenced by its Q2 ranking in both reproductive medicine and urology, it serves as a vital resource for researchers, healthcare professionals, and students looking to stay updated on the latest developments in andrology. The journal actively encourages submissions across a diverse range of topics, contributing to our understanding of male reproductive health issues, advancements in treatment protocols, and innovative therapeutic approaches. Located in the United Kingdom, Basic and Clinical Andrology plays a critical role in the global discourse on andrology, offering researchers an opportunity to share their findings with a broad audience committed to improving health outcomes in these crucial fields.

JOURNAL OF SPINAL CORD MEDICINE, published by Taylor & Francis Ltd, serves as a pivotal platform in the field of neurology, particularly focusing on spinal cord research and clinical practices. With an emphasis on advancing knowledge and clinical understanding, this journal has been committed to disseminating high-quality research since its inception in 1995 and continues its mission into 2024. Holding a Q3 ranking in the clinical neurology category, it is recognized among its peers, attracting a diverse readership of researchers, healthcare professionals, and students dedicated to the complexities of spinal cord medicine. Although it does not currently offer open access, it remains an authoritative source of innovative studies, systematic reviews, and case reports that contribute to enhancing patient care and clinical outcomes in the field. With an ISSN of 1079-0268 and an E-ISSN of 2045-7723, the journal stands out as an essential resource for those engaged in spinal cord medicine research and practice.

The Journal of Egyptian Women's Dermatological Society, published by Wolters Kluwer Medknow Publications, is an essential platform dedicated to advancing the field of dermatology through a valuable focus on women's health issues. Established to provide an open access outlet since 2019, this journal aims to disseminate research, case studies, and reviews that address the unique dermatological needs and concerns of women, particularly in the Egyptian context. Despite its current ranking in the Q4 category in dermatology and a Scopus rank of #117 out of 142 with a 17th percentile, the journal serves a critical role in fostering scholarly communication among researchers, clinicians, and academicians. With a commitment to promoting knowledge advancement and community engagement, this journal invites submissions that align with its objectives, specifically geared towards empirical research and innovative practices in dermatology impacting women's health.

Iraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.